Our objective was to evaluate the efficacy of @entity3459 in the treatment of @entity3146 . The study design consisted of a retrospective review of case records of all @entity1 treated with @entity3459 from the colposcopy clinics inception in 1980 to 1994. A total of 725 @entity1 received treatment with @entity3459 . All grades of @entity5 were treated. 632 (87.1%) had long term negative follow up. 93 (12.6%) of @entity1 had abnormal cytological follow up, but only 45 (6.2%) required re-treatment. Within the first year after treatment 52 (7.1%) @entity1 presented with persistent cytological abnormalities, 32 (4.4%) required repeated treatment for persistent dyskaryosis. 41 (5.6%) of @entity1 had recurrent cytological abnormalities, 13 (1.8%) required repeated treatment. Recurrence developed between two and 12 years from initial treatment. One case of @entity2622 following treatment with @entity3459 was recorded. Our data suggest that @entity3459 appears to be safe, efficient treatment for @entity3146 .

Efficacy of XXXX ( @entity5 ) treatment by @entity3459 .

@entity1 :: ('9606', 'Species') :: ['women', 'patients'] @entity5 :: ('MESH:D009369', 'Disease') :: ['CIN'] @entity2622 :: ('MESH:D002583', 'Disease') :: ['cervical carcinoma'] @entity3459 :: ('MESH:D025861', 'Disease') :: ['cold coagulation'] @entity3146 :: ('MESH:D018290', 'Disease') :: ['cervical intraepithelial neoplasia']
@entity5 :: (MESH:D009369,Disease) :: ['cervical intrarepithelial neoplasia']
